Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14008682 | 0.84 | TSHR (0.46) | TSHRRECQLALDH1A1L3MBTL1KMT2A | |
| SCHEMBL475682 | 0.84 | ALDH1A1 (0.51) | TSHRRECQLALDH1A1L3MBTL1KMT2A | |
| SCHEMBL10845666 | 0.82 | TSHR (0.48) | TSHRRECQLALDH1A1L3MBTL1KMT2A | |
| SCHEMBL1615758 | 0.81 | ALDH1A1 (0.33) | ALDH1A1L3MBTL1 | |
| SCHEMBL2219648 | 0.81 | CYP1A2 (0.46) | TSHRALDH1A1L3MBTL1KMT2ALMNA | |
| SCHEMBL9852007 | 0.79 | TSHR (0.41) | TSHRRECQLALDH1A1L3MBTL1KMT2A | |
| SCHEMBL9512578 | 0.78 | TSHR (0.40) | TSHRRECQLALDH1A1L3MBTL1KMT2A | |
| SCHEMBL17281804 | 0.78 | TSHR (0.40) | TSHRRECQLALDH1A1L3MBTL1KMT2A | |
| SCHEMBL29191943 | 0.78 | TSHR (0.40) | TSHRRECQLALDH1A1L3MBTL1KMT2A | |
| SCHEMBL15443091 | 0.77 | LMNA (0.44) | TSHRALDH1A1KMT2AMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260110607-A1 | TRANSPORT AND DETECTION OF EXPLOSIVE SAMPLES WITH MINIMIZED FALSE POSITIVES | ALTI LLC (US) | 2026-04-23 | — | — | US | claimed |
| US-12517047-B2 | Transport and detection of explosive samples | ALTI LLC (US) | 2026-01-06 | — | — | US | claimed |
| US-20250237601-A1 | TRANSPORT AND DETECTION OF EXPLOSIVE SAMPLES | ALTI LLC | 2025-07-24 | — | — | US | claimed |
| CN-115825299-B | Purity analysis method of 1-methyl-3, 4, 5-trinitropyrazole | 中北大学 | 2024-09-24 | — | — | CN | claimed |
| US-20230330136-A1 | BLOOD-BRAIN BARRIER-PENETRATING NANOTHERANOSTICS FOR ACUTE AND CHRONIC NEURODEGENERATIVE DISEASES AND THE LIKE | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2023-10-19 | — | — | US | claimed |
| EP-4204019-A1 | BLOOD-BRAIN BARRIER-PENETRATING NANOTHERANOSTICS FOR ACUTE AND CHRONIC NEURODEGENERATIVE DISEASES AND THE LIKE | The Governing Council of the University of Toronto (CA) | 2023-07-05 | — | — | EP | claimed |
| CN-114133306-B | CL-20 and 3,4-MDNP supermolecular explosive and preparation method thereof | 中国工程物理研究院化工材料研究所 | 2023-05-02 | — | — | CN | claimed |
| CN-115825299-A | Purity analysis method of 1-methyl-3, 4, 5-trinitropyrazole | 中北大学 | 2023-03-21 | — | — | CN | claimed |
| CN-115146131-B | Method for screening target active natural product and application thereof | 中国农业科学院蜜蜂研究所 | 2022-11-18 | — | — | CN | claimed |
| CN-115146131-A | Method for screening target active natural product and application thereof | 中国农业科学院蜜蜂研究所 | 2022-10-04 | — | — | CN | claimed |
| WO-2022067430-A1 | BLOOD-BRAIN BARRIER-PENETRATING NANOTHERANOSTICS FOR ACUTE AND CHRONIC NEURODEGENERATIVE DISEASES AND THE LIKE | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2022-04-07 | — | — | WO | claimed |
| CN-114133306-A | CL-20 and 3,4-MDNP supramolecular explosive and preparation method thereof | 中国工程物理研究院化工材料研究所 | 2022-03-04 | — | — | CN | claimed |
| CN-114031473-A | CL-20 and 3,5-MDNP supramolecular explosive and preparation method thereof | 中国工程物理研究院化工材料研究所 | 2022-02-11 | — | — | CN | claimed |
| EP-1854160-A2 | REDOX-ACTIVE STRUCTURES AND DEVICES UTILIZING THE SAME | YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) | 2007-11-14 | — | — | EP | claimed |
| WO-2006085319-A2 | REDOX-ACTIVE STRUCTURES AND DEVICES UTILIZING THE SAME | YEDA RESEARCH AND DEVELOPMENT COMPANY LTD. (IL) | 2006-08-17 | — | — | WO | claimed |
| US-20260110607-A1 | TRANSPORT AND DETECTION OF EXPLOSIVE SAMPLES WITH MINIMIZED FALSE POSITIVES | ALTI LLC (US) | 2026-04-23 | — | — | US | disclosed |
| CN-117487030-B | Maltodextrin nanoparticle and preparation method and application thereof | 重庆医科大学 | 2026-02-27 | — | — | CN | disclosed |
| WO-2006085319-A2 | REDOX-ACTIVE STRUCTURES AND DEVICES UTILIZING THE SAME | YEDA RESEARCH AND DEVELOPMENT COMPANY LTD. (IL) | 2006-08-17 | — | — | WO | disclosed |
| US-6610977-B2 | Security system for NBC-safe building | LOCKHEED MARTIN CORPORATION | 2003-08-26 | — | — | US | disclosed |
| US-4561862-A | Use of selected beta-nitroalkenes as cetane number boosters for diesel fuel | OLIN CORPORATION (US) | 1985-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260110607-A1 | TRANSPORT AND DETECTION OF EXPLOSIVE SAMPLES WITH MINIMIZED FALSE POSITIVES | TES, TNPO1, SLC2A1 | TSHR 3452/4885RECQL 369/4885ALDH1A1 4406/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.